oncology
1,857 projects
breast cancer168leukemia137skin cancer106prostate cancer99colorectal cancer78lung cancer67pancreatic cancer42liver cancer37cervical cancer10bladder cancer10head and neck cancer7
HEIndividual fellowship2027–2028Denmark
IRGOP · Immunometabolic Reprogramming via a Gut-derived Organoid Platform
HEIndividual fellowship2027–2028Denmark
click-to-cure · Exploitation of bioorthogonal click-to-release chemistry for precision cancer therapy
2 partners · 2 countries
HEIndividual fellowship2027–2030Spain
Photo-bioMOF · Designing Programmable MOF-nanocomposites for Synergistic, Redox-Driven Antitumor Therapies
3 partners · 2 countries
HEIndividual fellowship2027–2029Spain
RedLips · Beyond ROS: Red-Light Photocatalytic Liposomes for Hypoxia-Resistant Cancer Therapy
2 partners · 2 countries
HEIndividual fellowship2027–2028Germany
Lipid-Ex · Decoding the Lipidome of Adipose-Derived Extracellular Vesicles in Ovarian Cancer: Mechanistic Insight into Tumor-Adipose Crosstalk
2 partners
HEIndividual fellowship2027–2028Austria
GlycoIMPACT · Glycoengineering for Immune Modulation in Precision Anti-Cancer Therapies
2 partners · 2 countries
HEIndividual fellowship2027–2029Czechia
psDIPG-NG · Multifunctional Nanogel for Prolonged Immunoregulation and ECM Remodelling in Post-Surgical Diffuse Intrinsic Pontine Glioma: Organ-on-Chip Model
2 partners · 2 countries
HEIndividual fellowship2027–2029Spain
GlycoScope · Glycoproteins with homogeneous glycosylation to define unexplored lectin binding properties
HEIndividual fellowship2027–2029Germany
RIPAIR · A possible new role of type I interferon (IFN)-mediated survival of influenza A virus (IAV)-infected lung cells in lung repair
HEIndividual fellowship2027–2029United Kingdom
PeptimAIze · Revolutionazing Peptide Design through Multi-Property Optimization and Explainable AI
HEIndividual fellowship2027–2028Sweden
MitoSwitch · Functional Characterization of Redox Switches in Mitochondrial Metabolism
HEIndividual fellowship2027–2029United Kingdom
TargetCTC · Non-Hemolytic Biomolecular Nanoarchitectures for Targeting Circulating Tumor Cells to Arrest Metastasis
HEIndividual fellowship2027–2029United Kingdom
DuoLipo-TNP · Dual-Responsive Liposome Platform for Selective Delivery of Triphosphate Nucleotide Prodrugs in Triple-Negative Breast Cancer
2 partners · 2 countries
HEIndividual fellowship2027–2029Spain
IRM · Glutaminase Isoenzymes: Gatekeepers of Bioenergetics, Immunity, and Tumor Microenvironment in Diabetes-Induced Hepatocellular Carcinoma
HEIndividual fellowship2027–2029Italy
MCG-QUAD · Machine Learning-Enhanced Coarse-Grained Modelling of Telomeric G-Quadruplex Multimers: A Multiscale Study
HEIndividual fellowship2026–2029Germany
GPMVreconstituteEGFR · EGFR protein condensation as a regulator of Ras activity
2 partners · 2 countries
HEDoctoral network2026–2030Germany
PANDORA · Doctoral network on discovering pathomechanisms and novel drug optimization for AMD
16 partners · 8 countries
HEDoctoral network2026–2030Belgium
SPACE-MEL · SPAtial single-CEll omics research training for MELanoma precision medicine
20 partners · 9 countries
HEDoctoral network2026–2030Netherlands
ORFeus · Decoding the dark proteome through interdisciplinary training and research
33 partners · 12 countries
HEIndividual fellowship2026–2028Finland
MarkovForScreening · Risk-Stratified and Personalized Cancer Screening with Bidirectional Multistate Markov Models
2 partners · 2 countries
HEStaff exchange2026–2030Italy
EXPOSES · European staff EXchange Programme fOr deSigning pErSonalised prevention of future healthcare
17 partners · 10 countries
HEIndividual fellowship2026–2028United Kingdom
PREDiCT-AI · AI-Driven Drug Discovery: Pancreatic Cancer Resistance via ENT1 Differential Conformation Tracking
2 partners · 2 countries
HEIndividual fellowship2026–2028Spain
MICROMATCH · Microwave photonics platform for cancer detection and treatment
HEStaff exchange2026–2030United Kingdom
MagBIO · Living magnetobots for targeted theranostics to tackle metastatic solid tumours
18 partners · 9 countries